Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients. | Aging (Albany NY) | 2023 | 37737707 | PubTator, text mining | PubMed |
| Cell-intrinsic and -extrinsic effects of SARS-CoV-2 RNA on pathogenesis: single-cell meta-analysis. | mSphere | 2023 | 37737611 | PubTator, text mining | PubMed |
| Astrocytes evoke a robust IRF7-independent type I interferon response upon neurotropic viral infection. | J Neuroinflammation | 2023 | 37737190 | PubTator, text mining | PubMed |
| Systematic Analysis of Long Non-Coding RNAs in Inflammasome Activation in Monocytes/Macrophages. | Noncoding RNA | 2023 | 37736896 | PubTator, text mining | PubMed |
| Immunomodulatory biomaterials against bacterial infections: Progress, challenges, and future perspectives. | Innovation (Camb) | 2023 | 37732016 | PubTator, text mining | PubMed |
| Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing. | Arthritis Res Ther | 2023 | 37730603 | PubTator, text mining | PubMed |
| COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing. | BMC Med Genomics | 2023 | 37723519 | PubTator, text mining | PubMed |
| Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation. | Nat Commun | 2023 | 37714849 | PubTator, text mining | PubMed |
| The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). | Oncol Rep | 2023 | 37711048 | PubTator, text mining | PubMed |
| Molecular basis of TASL recruitment by the peptide/histidine transporter 1, PHT1. | Nat Commun | 2023 | 37709742 | PubTator, text mining | PubMed |
| Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry. | RMD Open | 2023 | 37709528 | PubTator, text mining | PubMed |
| Signaling pathways in macrophages: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37706196 | PubTator, text mining | PubMed |
| Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer. | World J Clin Oncol | 2023 | 37700807 | PubTator, text mining | PubMed |
| CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy. | J Transl Med | 2023 | 37684649 | PubTator, text mining | PubMed |
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682177 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. | Front Immunol | 2023 | 37675100 | PubTator, text mining | PubMed |
| Quartet protein reference materials and datasets for multi-platform assessment of label-free proteomics. | Genome Biol | 2023 | 37674236 | PubTator, text mining | PubMed |
| Molecular characteristics and therapeutic implications of Toll-like receptor signaling pathway in melanoma. | Sci Rep | 2023 | 37666853 | PubTator, text mining | PubMed |
| Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway. | Cancer Cell Int | 2023 | 37649034 | PubTator, text mining | PubMed |
| Dichotomous roles of RIPK3 in regulating the IFN response and NLRP3 inflammasome in human monocytes. | J Leukoc Biol | 2023 | 37648661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=17